Skip to content

Research on eustachian tube pressure nebulization and insu?ation system in the treatment of otitis media with e?usion

Clinical e?cacy and optimization measure of eustachian tube pressure nebulization and insu?ation system in the treatment of otitis media with e?usion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106816
Enrollment
Unknown
Registered
2025-07-30
Start date
2025-08-09
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

otitis media with effusion, hearing loss, ear stuffy, tinnitus, earache

Interventions

Drug treatment group:Simple drug therapy
Combined treatment group:Drug combined with pressure nebulization and blowing therapy of the eustachian tube

Sponsors

Beijing Jishuitan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. At the patient's first visit, the otoendoscopy indicated normal tympanic membrane, tympanic membrane retraction or fluid accumulation in the tympanic cavity; 2. Pure tone audiometry indicates conductive deafness or normal hearing,and tympanometry show B or C curve; 3. Age >= 18;

Exclusion criteria

Exclusion criteria: 1. The patient was accompanied by symptoms of acute upper respiratory tract infection such as purulent nasal discharge, cough and expectoration; 2. Drug allergy or inability to use; 3. The presence of structural obstructive diseases such as nasal polyps and nasal masses affects treatment; 4. Congenital cleft palate, or congenital atresia or stenosis of the pharyngeal orifice of the eustachian tube, or other systemic diseases;

Design outcomes

Primary

MeasureTime frame
Tympanometry;

Secondary

MeasureTime frame
ETDQ-7;pure tone audiometry;ETS-5;

Countries

China

Contacts

Public ContactYang Jing

Beijing Jishuitan Hospital, Capital Medical University

yjshmilycindy@163.com+86 13240154969

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026